ADDICTIVE BEHAVIORSVol. 29, No. 2, 2004Continued from outside back cover323 Risk factors for pathological gambling337 Social reinforcem<strong>en</strong>t of substance abuse treatm<strong>en</strong>t aftercareparticipation: Impact on outcome343 Predictors of curr<strong>en</strong>t need to smoke in inmates of a smokefreejail349 Cotinine as a biomarker of systemic nicotina exposure in spittobacco users357 Characteristics of cigarette smokers seeking treatm<strong>en</strong>t forcessation versus reduction365 Factors associated with adverse reactions to cocaine among asample of long-term, high-dose users in Sao Paulo, Brazil375 G<strong>en</strong>der differ<strong>en</strong>ces in the association among nicotinedep<strong>en</strong>d<strong>en</strong>ce, body image, depression, and anxiety within a collegepopulation381 Evaluation of an alternative methodology for investigatingleadership and binge drinking among sorority membersJohn W. WelteGrace M. Barnes WilliamF. Wieczorek Maríe-Cecile O. Tidwell JohnC. ParkerStev<strong>en</strong> J. LashJ<strong>en</strong>nifer L. Burd<strong>en</strong>Brian R. MoníeleoneLaur<strong>en</strong> P. LehmannJ. Paul Voglewede Jr.Nora E. NoelJon O. Ebbert Lowell C.Dale Liza M. NirelliDarrell fí. SchroederThomas P. MoyerRichard D. HurtCharlotte A. LemmondsMaro Mooney BrianReich DorothyHatsukamiCleusa P. Ferri JohnDunn Michael GossopRonaldo LaranjeiraJessica K. PsujekD<strong>en</strong>ise M. Martz LisaCurtin Kurt D. MichaelStanley R. AeschlemanJonathan A. PluckerCarla M. Teed389 "Who gets in?" Recruitm<strong>en</strong>t and scre<strong>en</strong>ing processes ofoutpati<strong>en</strong>t substance abuse trialsShelly L. Sayre MarkEvans Patricia S.Hokanson Joy M.Schmitz Angela L. StottsPatricia Averill JohnGrabowski399405413425433SHORT COMMUNICATIONSAwar<strong>en</strong>ess of indep<strong>en</strong>d<strong>en</strong>ce of ev<strong>en</strong>ts and erroneousperceptions while gamblingVerification of adolesc<strong>en</strong>t self-reported smokingPreval<strong>en</strong>ce and correlates of past-year substance use,abuse, and dep<strong>en</strong>d<strong>en</strong>ce in a suburban community sample ofhigh-school stud<strong>en</strong>tsSmoking among female prisoners: An ignored publichealth epidemicDiffer<strong>en</strong>t variables are associated with help-seeking patternsand long-term outcomes among problem drinkersKarim B<strong>en</strong>hsainAlain TailleferRobert LadouceurJukka K<strong>en</strong>talaPekka Utriain<strong>en</strong>Kimmo PahkalaKari MattilaKevin Ch<strong>en</strong> Alpa J.Sheth Deborah K.Elliott Andy YeagerKar<strong>en</strong> CropseyGloria D. EldridgeTina LadnerJalie A. TuckerRudy E. VuchinichPaula D. Ripp<strong>en</strong>s
adicciones Monografía Drogas recreativas. Vol. 15 suplem<strong>en</strong>to 2PRESENTACIÓN. Preface.Robles, G. ............................................................................................................................................................................................................................ 51. JÓVENES, FIN DE SEMANA Y USO RECREATIVO DE DROGAS: EVOLUCIÓN YTENDENCIAS DEL OCIO JUVENIL. Youth,week-<strong>en</strong>d and recreative use of drugs: evolution and t<strong>en</strong>d<strong>en</strong>cies in leisure among the youth.Rodríguez, J.; Agulló, E.; Agulló, M a . S..................................................................................................................................................................................72. EVOLUCIÓN HISTÓRICA DEL USO Y ABUSO DE MDMA. Historical developm<strong>en</strong>t of MDMA use and abuse.Sáiz, P.A.; García-Portilla; M a P; Paredes, B.; Bobes, J................................................................................................................................................................353. CARACTERÍSTICAS FARMACOLÓGICAS DE LAS DROGAS RECREATIVAS (MDMAY OTRAS ANFETAMINAS, KETAMINA, GHB, LSD Y OTROSALUCINÓGENOS). Pharmacological properties of recreational drugs (MDMA and others amphetamins, ketamine, GHB, LSD and otherhallucinog<strong>en</strong> drugs).Lor<strong>en</strong>zo, P;Lizasoain, I................................................................................................................................................................................................ 514. TENDENCIAS, CARACTERÍSTICAS Y PROBLEMAS ASOCIADOS AL CONSUMO DE DROGAS RECREATIVAS EN ESPAÑA. T<strong>en</strong>d<strong>en</strong>cies,characterístics, and problema associated with the consumption of recreational drugs in Spain.Infante, C.; Barrio, G.; Martín, E.................................................................................................................................................................................. 775. APROXIMACIÓN TOXICOLÓGICA A LOS PSICOESTIMULANTES UTILIZADOS CON FINES RECREATIVOS. Toxicologic approach topsychostimulants used in recreational settings.Luna, A.......................................................................................................................................................................................................…....................... 976. NEUROIMAGEN Y NEUROTOXICIDAD INDUCIDA POR MDMA (ÉXTASIS). Neuroimaging MDMA-induced neurotoxicity.Ricaurte, G.; McCann, U............................................................................................................................................................................................................... 1117. ESTUDIOS CONTROLADOS EN HUMANOS DE ÉXTASIS. Controlled triáis of ecstasy administration in humans.Parré, M.; Roset, P N.; de la Torre, fí.; Abanadas, S,; Peiró, A. M a ;Alvarez, Y: Pizarro, A/.; Segura, M.; Camí, J....................................................... 1218. KETAMINA: NUEVAS OBSERVACIONES SOBRE SU CONSUMO, CONSUMIDORES Y EFECTOS. Ketamine: further observations on use,users and consequ<strong>en</strong>ces.Jans<strong>en</strong>, KLR.; Theron, L.......................................................... ………………………………........................................................................................ 1359. GHB: UN ANÁLISIS. GHB: an overview.Deg<strong>en</strong>hardt, L. ............................................................................................................................................................................................................ 16710. LSD Y ALUCINÓGENOS. LSD and hallucinog<strong>en</strong>s.Solé,J........................................................................................................................................................................................................................ 17911. PERSONALIDAD Y USO-ABUSO DE ÉXTASIS (MDMA). Personality and use-abuse of ecstasy (MDMA).G-Portilla, M 3 P; Sáiz, P; Paredes, B.; Martínez, S.; Bobes, J................................................................................................................................. 19912. COMPLICACIONES FÍSICAS DEL CONSUMO DE DROGAS RECREATIVAS. Physical complications of recreational drug use.Ojeda, E.; Martínez, J.; Castellano, M.; Pérez, B.; Sabater, A.; Cervera, G....................................................................................................................... 20713. COMPLICACIONES PSICOPATOLÓGICAS ASOCIADAS AL CONSUMO DE DROGAS RECREATIVAS. Psychopathological complicationsassociated to recreational drug consumption.Sáiz, P A.; García-Portilla, M a P; Martínez, S.; Bascarán, M a ; Bousoño,M.;Bobes,J.............................................................................................. 21714. CARACTERÍSTICAS DE LOS CONSUMIDORES DE DROGAS RECREATIVAS EN ESPAÑA Y OTROS PAÍSES EUROPEOS.Characteristics of users of recreational drugs in Spain and other EU member countries.Fernández, ................ ..................................................................................................................................................................................................... 23315. DE LA ETIOLOGÍA A LA PREVENCIÓN DEL USO Y ABUSO DE DROGAS RECREATIVAS. From ethiology to the prev<strong>en</strong>tionof recreational drug use and abuse.Calafat,A.;Juan, M..................................................................................................................................................................................................... ....26116. CONSUMO RECREATIVO DE DROGASY REDUCCIÓN DE DAÑOS EN LA VIDA NOCTURNA GLOBALGlobal nightlife: recreational drug use and harm minimisation.Be/lis, M. A.; Hughes, K...........................…………………............................................................................................................................................. 28917 ANÁLISIS DE PASTILLAS COMO PREVENCIÓN SELECTIVA. Pili testing as selectivo prev<strong>en</strong>tion.Burkhart, G.; Kri<strong>en</strong>er, H........……………….................................................................................................................................................................... 30718. PROGRAMAS DE PREVENCIÓN DE OCIO ALTERNATIVO. Prev<strong>en</strong>tion programs on alternative activities.Martín, E.; Moncada, S................................................................................................................................................................................. 32719. APROXIMACIÓN TERAPÉUTICA AL USO Y ABUSO DE DROGAS RECREATIVAS. Therapeutic strategies in recreational drugs.Landabaso, M.A.; Gutiérrez, M....................................................................................................................................................................................... 34720. PROGRAMAS DE REDUCCIÓN DE DAÑOS EN USO/ABUSO DE DROGAS RECREATIVAS. Harm reduction programs and use and abuse ofrecreational drugs.Valverde, C.; Pi, J.; Colom, J......................................................................................................................................................................... 35321. LAS DROGAS DE USO RECREATIVO EN EL DERECHO PENAL ESPAÑOL. Recreational drugs in the spanish p<strong>en</strong>al code.Herrero, S.......................................................................................................................................................................................................................... 361
- Page 1 and 2:
PresentaciónSu elaboración en for
- Page 6 and 7:
• FUENTES GONZALEZ G. (2003). PRO
- Page 8 and 9:
• SAUNDERS J., YOUNG R. (2002). A
- Page 10 and 11:
• LUNA MALDONADO A. (2003). APROX
- Page 12 and 13:
• HANAK C., TECCO J., VERBANCK P.
- Page 14 and 15:
• MARTÍNEZ GONZÁLEZ J.M. (2003)
- Page 16 and 17:
• COMAS ARNAU D.; coord. AGUINAGA
- Page 18 and 19:
• RANZETTA L., FITZPTRICK J., SEL
- Page 20 and 21:
• CASTELLO NICAS N. (2003). EXENC
- Page 22 and 23:
• LUNA JIMENEZ DE PARGA P., GALLA
- Page 24 and 25: • VALLS PRIETO J. (2003). LEGISLA
- Page 26: • KUHN C., SWARTZWELDER S., WILSO
- Page 29 and 30: • NATIONAL INSTITUTE ON DRUG ABUS
- Page 31 and 32: • BRAVO D. (2001). UNIDAD MOVIL D
- Page 33 and 34: • GOLTZMAN P., CYMERMAN P., ROSSI
- Page 35 and 36: • RADULICH G.C., VIVAS L.E., BRUN
- Page 37 and 38: • VITORIA ISUSI A.; coord., ALVAR
- Page 39 and 40: • JIMENEZ M., MONASOR R.,RUBIO VA
- Page 41 and 42: • CALAFAT FAR A., JUAN M. (2003).
- Page 43 and 44: • SASOIA. EDUCACION PARA LA SALUD
- Page 45 and 46: • LADERO QUESADA J.M., MARTIN DEL
- Page 47 and 48: • LADERO QUESADA J.M., MARTIN DEL
- Page 49 and 50: • JOHANSSON B.A. (2003). PHARMACO
- Page 51 and 52: • ESPAÑA. MINISTERIO DE SANIDAD
- Page 53 and 54: • ANDALUCIA (COMUNIDAD AUTONOMA).
- Page 55 and 56: • JENSEN E.L. (2003). SANCIONES N
- Page 57 and 58: • NACIONES UNIDAS. PROGRAMA MUNDI
- Page 59 and 60: • ESPAÑA. PLAN NACIONAL SOBRE DR
- Page 61 and 62: BOE 16/12/2003MINISTERIO DEL INTERI
- Page 63 and 64: BOE 19/12/2003COMUNIDAD AUTÓNOMA D
- Page 65 and 66: Addiction .........................
- Page 67 and 68: AddictionVOLUME 98 • SUPPLEMENT 2
- Page 69 and 70: ………….ADDICTIVE BEHAVIORSAN
- Page 71 and 72: ADDICTIVE BEHAVIORSAN INTERNATIONAL
- Page 73: ADDICTIVE BEHAVIORSAN INTERNATIONAL
- Page 77 and 78: THE AMERICAN JOURNAL OF DRUG AND AL
- Page 79 and 80: CDD DDZCentro de Documentaciónde d
- Page 81 and 82: CDD DDZCentro de Documentaciónde d
- Page 83 and 84: DRUG andALCOHOLDEPENDENCEVolume 72,
- Page 85 and 86: DRUG andALCOHOLDEPENDENCEVolume 73,
- Page 87 and 88: IDEA prevenciónnº 27 julio/diciem
- Page 89 and 90: Volume 22 Number 3 2003CONTENTSEDIT
- Page 91 and 92: Buprenorphine for Opiate Dependence
- Page 93 and 94: Circuit Parties and Patterns of Dru
- Page 95 and 96: 963 Towards an HIV Role Theory: Dru
- Page 97 and 98: Drug Use Among Texas Alternative Sc
- Page 99 and 100: Contents (continued)GOLDSTEIN, A.L.
- Page 101 and 102: Journal of Substance Abuse Treatmen
- Page 103 and 104: Journal of Substance Abuse Treatmen
- Page 105 and 106: PSYCHOLOGY OFADDICTIVE BEHAVIORSVol
- Page 107 and 108: PUBLIC HEALTH ReportVOLUME 118 NUMB
- Page 109 and 110: PUBLIC HEALTH ReportVOLUME 118 NUMB
- Page 111 and 112: PUBLIC HEALTH ReportVOLUME 118 NUMB
- Page 113 and 114: REVISTA DE ESTUDIOS DE JUVENTUDNº
- Page 115 and 116: RTS - REVISTA DE TREBALL SOCIALNúm
- Page 117 and 118: Contents ContinuedRESEARCH NOTESCli
- Page 119 and 120: TOBACCO CONTROLDecember 2003Vol. 12
- Page 121: trastornosadictivosVolumen 6 • N
Change language